Abstract:LB-115 Mitochondrial malfunction, which can lead to decreased ATP generation through oxidative phosphorylation and altered drug sensitivity, has long been observed in many cancer cells, but the underlying mechanisms remain to be investigated. Here we report the establishment of an inducible cell model in which the mitochondrial respiratory function can be controlled by tetracycline and the use of this system as a tool to investigate on the relationship between mitochondrial respiratory malfunction, redox alterations, and drug sensitivity. A dominant negative form of the DNA polymerase gamma (POLGdn) was expressed in the T-ReX293 tetracycline inducible system. Mitochondrial malfunction was induced by doxocycline, which led to a almost complete suppression of oxygen consumption, caused by a depletion of the mitochondrial DNA-encoded respiratory chain complex I, III, IV, and V components, despite an increase of nuclear encoded complex II subunit proteins. Accompany with this mitochondrial respiratory defect, superoxide generation from the respiratory chain decreased, whereas cellular hydrogen peroxide level increased, as shown by fluorometric detection using hydroethedine and DCF-DA, respectively. The increase in hydrogen peroxide level was further confirmed by using the catalase to eliminate its specific fluorescent signal. Surprisingly, cellular nitric oxide level also increased when mitochondrial respiration was suppressed. The increase in nitric oxide could be inhibited by the NOS inhibitor L-NMMA. Biochemical analyses showed total cellular glutathione content and the expression of glutathione peroxidase (GPX-1) protein were elevated in the mitochondrial defective cells, whereas the levels of SOD1 and SOD2 proteins remained unchanged. These alterations in cellular redox states were associated with significant changes (increase or decrease) in cellular sensitivity to anticancer agents, depending on the mechanisms of action of the specific drugs. Compounds with pro-oxidant property are more effective in killing the cells with increased hydrogen peroxide and nitric oxide. These observations may have clinical implications in selecting proper drug to kill cancer cells with mitochondrial dysfunction.

Mitochondrial Respiratory Defects Lead to Significant Alterations in Cellular Redox States and Drug Sensitivity